| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.631 | 0.014 | 0.631 | MAP kinase 1 inhibitor | 0.285 0.197 DBMET02746 0.303 0.176 DBMET02748 | ||
| 0.492 | 0.002 | 0.492 | Insulin receptor antagonist | 0.279 0.005 DBMET02746 0.245 0.008 DBMET02748 0.211 0.013 DBMET02745 0.093 0.072 DBMET02747 | ||
| 0.491 | 0.006 | 0.491 | Death-associated protein kinase 3 inhibitor | 0.436 0.012 DBMET02746 0.441 0.011 DBMET02748 0.387 0.019 DBMET02745 0.321 0.033 DBMET02747 0.202 0.074 DBMET02749 | ||
| 0.394 | 0.013 | 0.394 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.275 0.036 DBMET02746 0.201 0.072 DBMET02748 0.224 0.055 DBMET02745 0.192 0.08 DBMET02747 0.147 0.138 DBMET02749 | ||
| 0.413 | 0.035 | 0.413 | Nootropic | 0.321 0.064 DBMET02746 0.25 0.108 DBMET02748 0.201 0.156 DBMET02745 | ||
| 0.415 | 0.049 | 0.415 | Angiogenesis inhibitor | 0.356 0.069 DBMET02746 0.284 0.101 DBMET02748 0.202 0.167 DBMET02745 0.219 0.149 DBMET02749 | ||
| 0.364 | 0.018 | 0.364 | CDC-like kinase 2 inhibitor | 0.27 0.039 DBMET02746 0.292 0.033 DBMET02748 0.214 0.059 DBMET02745 0.146 0.096 DBMET02747 | ||
| 0.339 | 0.026 | 0.339 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.223 0.062 DBMET02746 0.246 0.052 DBMET02748 0.287 0.04 DBMET02745 | ||
| 0.318 | 0.007 | 0.318 | Cyclin-dependent kinase 8 inhibitor | 0.199 0.036 DBMET02746 0.232 0.021 DBMET02748 0.15 0.079 DBMET02745 | ||
| 0.326 | 0.016 | 0.36 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.36 0.013 DBMET02746 0.182 0.042 DBMET02748 0.088 0.087 DBMET02745 0.168 0.046 DBMET02747 | DBMET02746 | |
| 0.317 | 0.01 | 0.317 | Cyclin-dependent kinase 7 inhibitor | 0.245 0.021 DBMET02746 0.261 0.019 DBMET02748 0.207 0.031 DBMET02745 0.158 0.054 DBMET02747 0.11 0.092 DBMET02749 | ||
| 0.331 | 0.029 | 0.331 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.183 0.072 DBMET02746 0.217 0.057 DBMET02748 0.246 0.046 DBMET02745 | ||
| 0.32 | 0.021 | 0.32 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.283 0.03 DBMET02746 0.275 0.032 DBMET02748 0.224 0.043 DBMET02745 0.157 0.072 DBMET02747 | ||
| 0.371 | 0.077 | 0.371 | MAP kinase kinase 6 inhibitor | 0.305 0.131 DBMET02746 0.297 0.138 DBMET02748 0.274 0.162 DBMET02745 0.237 0.208 DBMET02747 | ||
| 0.314 | 0.023 | 0.314 | TRKC antagonist | 0.214 0.061 DBMET02746 0.252 0.047 DBMET02748 0.17 0.086 DBMET02745 | ||
| 0.308 | 0.026 | 0.308 | MAP-kinase-activated kinase 5 inhibitor | 0.243 0.064 DBMET02746 0.294 0.034 DBMET02748 0.281 0.041 DBMET02745 0.179 0.133 DBMET02747 | ||
| 0.288 | 0.007 | 0.288 | MAP kinase 8 inhibitor | 0.2 0.016 DBMET02746 0.156 0.027 DBMET02748 0.167 0.024 DBMET02745 0.105 0.055 DBMET02747 | ||
| 0.319 | 0.039 | 0.576 | Tyrosine kinase inhibitor | 0.283 0.046 DBMET02746 0.576 0.012 DBMET02748 0.124 0.105 DBMET02745 0.165 0.082 DBMET02747 | DBMET02748 | |
| 0.283 | 0.01 | 0.283 | MAP kinase kinase inhibitor | 0.1 0.095 DBMET02746 | ||
| 0.311 | 0.04 | 0.311 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.173 0.094 DBMET02746 0.186 0.084 DBMET02748 0.188 0.082 DBMET02745 | ||
| 0.294 | 0.025 | 0.294 | Protein kinase C nu inhibitor | 0.176 0.057 DBMET02746 0.227 0.039 DBMET02748 0.264 0.032 DBMET02745 0.111 0.104 DBMET02747 | ||
| 0.286 | 0.019 | 0.286 | Protein kinase (CK1) gamma 3 inhibitor | 0.222 0.036 DBMET02746 0.218 0.038 DBMET02748 0.192 0.052 DBMET02745 0.149 0.091 DBMET02747 | ||
| 0.264 | 0.005 | 0.264 | Insulin growth factor antagonist | 0.101 0.046 DBMET02746 0.125 0.031 DBMET02748 | ||
| 0.279 | 0.02 | 0.279 | Tyrosine-protein kinase receptor antagonist | 0.156 0.061 DBMET02748 | ||
| 0.264 | 0.006 | 0.264 | MAP kinase 3 inhibitor | 0.2 0.023 DBMET02746 0.197 0.025 DBMET02748 0.228 0.013 DBMET02745 0.137 0.091 DBMET02747 | ||
| 0.263 | 0.014 | 0.325 | Vascular endothelial growth factor 1 antagonist | 0.325 0.009 DBMET02746 0.135 0.047 DBMET02748 0.102 0.064 DBMET02745 0.15 0.041 DBMET02747 | DBMET02746 | |
| 0.264 | 0.017 | 0.264 | TRKA antagonist | 0.143 0.054 DBMET02748 | ||
| 0.28 | 0.038 | 0.28 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.186 0.072 DBMET02746 0.211 0.062 DBMET02748 0.14 0.103 DBMET02745 | ||
| 0.245 | 0.005 | 0.245 | Insulin like growth factor 1 antagonist | 0.088 0.051 DBMET02746 0.11 0.034 DBMET02748 | ||
| 0.257 | 0.021 | 0.257 | Glycogen synthase kinase-3 inhibitor | 0.156 0.044 DBMET02746 0.177 0.037 DBMET02748 0.178 0.037 DBMET02745 | ||
| 0.246 | 0.016 | 0.246 | MAP kinase 9 inhibitor | 0.158 0.035 DBMET02746 0.123 0.048 DBMET02748 0.107 0.057 DBMET02745 | ||
| 0.262 | 0.033 | 0.262 | Growth factor antagonist | 0.227 0.04 DBMET02746 0.123 0.089 DBMET02748 | ||
| 0.24 | 0.019 | 0.24 | Aurora-A kinase inhibitor | 0.13 0.049 DBMET02746 0.154 0.038 DBMET02748 0.093 0.072 DBMET02745 0.089 0.075 DBMET02747 | ||
| 0.228 | 0.01 | 0.228 | Polo-like kinase-4 inhibitor | 0.157 0.032 DBMET02746 0.197 0.016 DBMET02748 0.133 0.047 DBMET02745 0.107 0.069 DBMET02747 | ||
| 0.227 | 0.009 | 0.227 | ALK inhibitor | 0.127 0.026 DBMET02746 0.139 0.022 DBMET02748 0.107 0.037 DBMET02745 | ||
| 0.238 | 0.022 | 0.238 | Glycogen synthase kinase-3 beta inhibitor | 0.129 0.055 DBMET02746 0.166 0.037 DBMET02748 0.174 0.035 DBMET02745 | ||
| 0.258 | 0.042 | 0.773 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.205 0.073 DBMET02746 0.218 0.064 DBMET02748 0.773 0.003 DBMET02742 0.176 0.096 DBMET02745 | DBMET02742 | |
| 0.342 | 0.129 | 0.499 | Cyclophilin D inhibitor | 0.246 0.218 DBMET02748 0.499 0.05 DBMET02749 | DBMET02749 | |
| 0.235 | 0.023 | 0.235 | Aurora-B kinase inhibitor | 0.107 0.074 DBMET02748 | ||
| 0.252 | 0.045 | 0.252 | CDC-like kinase 4 inhibitor | 0.168 0.087 DBMET02746 0.204 0.065 DBMET02748 | ||
| 0.22 | 0.013 | 0.277 | Fibroblast growth factor 1 antagonist | 0.277 0.007 DBMET02746 0.135 0.037 DBMET02748 0.091 0.065 DBMET02745 0.16 0.028 DBMET02747 | DBMET02746 | |
| 0.216 | 0.009 | 0.216 | Cyclin A2 inhibitor | 0.056 0.05 DBMET02746 0.064 0.044 DBMET02748 | ||
| 0.235 | 0.029 | 0.351 | Polo-like kinase-3 inhibitor | 0.351 0.005 DBMET02746 0.14 0.096 DBMET02748 0.128 0.113 DBMET02745 0.314 0.009 DBMET02747 | DBMET02746 | |
| 0.234 | 0.03 | 0.457 | Protein kinase (CK1) inhibitor | 0.149 0.069 DBMET02746 0.185 0.046 DBMET02748 0.457 0.005 DBMET02742 | DBMET02742 | |
| 0.236 | 0.034 | 0.236 | RET inhibitor | 0.11 0.087 DBMET02746 0.109 0.088 DBMET02748 | ||
| 0.255 | 0.053 | 0.255 | Clk dual-specificity kinase inhibitor | 0.162 0.103 DBMET02746 0.19 0.085 DBMET02748 | ||
| 0.235 | 0.034 | 0.235 | Protein kinase (CK1) gamma inhibitor | 0.165 0.059 DBMET02746 0.175 0.054 DBMET02748 0.123 0.087 DBMET02745 | ||
| 0.231 | 0.033 | 0.231 | Protein kinase (CK1) gamma 1 inhibitor | 0.166 0.057 DBMET02746 0.166 0.057 DBMET02748 0.134 0.083 DBMET02745 | ||
| 0.206 | 0.009 | 0.206 | Cyclin A inhibitor | 0.052 0.051 DBMET02746 0.062 0.043 DBMET02748 | ||
| 0.25 | 0.06 | 0.25 | Antimitotic | 0.221 0.073 DBMET02746 | ||
| 0.198 | 0.01 | 0.198 | Leucine-rich repeat kinase 2 inhibitor | 0.071 0.067 DBMET02746 0.08 0.058 DBMET02748 | ||
| 0.221 | 0.034 | 0.575 | Vascular endothelial growth factor antagonist | 0.172 0.047 DBMET02746 0.095 0.087 DBMET02748 0.575 0.005 DBMET02747 | DBMET02747 | |
| 0.195 | 0.014 | 0.195 | p38 MAP kinase inhibitor | 0.076 0.042 DBMET02746 0.074 0.043 DBMET02748 0.147 0.02 DBMET02745 | ||
| 0.187 | 0.009 | 0.187 | Protein kinase B gamma inhibitor | 0.143 0.018 DBMET02746 0.185 0.009 DBMET02748 0.137 0.02 DBMET02745 0.076 0.05 DBMET02747 | ||
| 0.206 | 0.027 | 0.547 | Protein kinase (CK1) delta inhibitor | 0.139 0.06 DBMET02746 0.172 0.041 DBMET02748 0.547 0.004 DBMET02742 0.102 0.09 DBMET02745 | DBMET02742 | |
| 0.19 | 0.011 | 0.19 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.102 0.044 DBMET02746 0.086 0.061 DBMET02748 | ||
| 0.227 | 0.05 | 0.227 | Focal adhesion kinase 2 inhibitor | |||
| 0.216 | 0.041 | 0.216 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.111 0.091 DBMET02746 0.136 0.073 DBMET02748 0.135 0.074 DBMET02745 | ||
| 0.238 | 0.067 | 0.238 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.156 0.136 DBMET02746 0.151 0.143 DBMET02748 | ||
| 0.212 | 0.042 | 0.431 | Protein-tyrosine kinase Lyn inhibitor | 0.168 0.058 DBMET02746 0.431 0.005 DBMET02747 | DBMET02747 | |
| 0.198 | 0.029 | 0.304 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.269 0.015 DBMET02746 0.108 0.08 DBMET02748 0.304 0.011 DBMET02747 | DBMET02747 | |
| 0.198 | 0.029 | 0.303 | Abl kinase inhibitor | 0.269 0.015 DBMET02746 0.107 0.079 DBMET02748 0.303 0.011 DBMET02747 | DBMET02747 | |
| 0.203 | 0.034 | 0.556 | Vascular endothelial growth factor 2 antagonist | 0.142 0.052 DBMET02746 0.556 0.006 DBMET02747 | DBMET02747 | |
| 0.181 | 0.017 | 0.181 | CDK2/cyclin A inhibitor | 0.131 0.035 DBMET02746 0.137 0.031 DBMET02748 0.117 0.044 DBMET02745 0.085 0.074 DBMET02747 | ||
| 0.18 | 0.019 | 0.18 | EphA2 antagonist | 0.132 0.043 DBMET02746 0.112 0.063 DBMET02745 0.098 0.077 DBMET02747 | ||
| 0.181 | 0.025 | 0.181 | MAP kinase 13 inhibitor | 0.129 0.049 DBMET02746 0.146 0.038 DBMET02748 0.124 0.052 DBMET02745 | ||
| 0.182 | 0.028 | 0.182 | Cyclin-dependent kinase 2 inhibitor | 0.109 0.061 DBMET02746 0.137 0.044 DBMET02748 0.101 0.068 DBMET02745 | ||
| 0.255 | 0.102 | 0.26 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.26 0.097 DBMET02745 | DBMET02745 | |
| 0.187 | 0.036 | 0.187 | Protein kinase (CK1) gamma 2 inhibitor | 0.131 0.058 DBMET02746 0.139 0.054 DBMET02748 0.1 0.083 DBMET02745 | ||
| 0.232 | 0.081 | 0.27 | Dyrk kinase inhibitor | 0.27 0.063 DBMET02742 | DBMET02742 | |
| 0.16 | 0.014 | 0.204 | Polo-like kinase-1 inhibitor | 0.204 0.006 DBMET02746 | DBMET02746 | |
| 0.188 | 0.042 | 0.188 | Ribosomal protein S6 kinase inhibitor | 0.117 0.094 DBMET02746 0.163 0.056 DBMET02748 | ||
| 0.204 | 0.059 | 0.204 | Growth factor agonist | |||
| 0.172 | 0.032 | 0.276 | Ephrin antagonist | 0.276 0.011 DBMET02746 0.217 0.02 DBMET02747 | DBMET02746 | |
| 0.159 | 0.022 | 0.16 | Protein kinase C mu inhibitor | 0.101 0.056 DBMET02746 0.137 0.032 DBMET02748 0.16 0.022 DBMET02745 0.083 0.076 DBMET02747 0.085 0.074 DBMET02749 | DBMET02745 | |
| 0.214 | 0.078 | 0.214 | EphB2 antagonist | |||
| 0.164 | 0.029 | 0.164 | MAP kinase kinase kinase inhibitor | |||
| 0.203 | 0.069 | 0.203 | I kappa B kinase epsilon inhibitor | |||
| 0.325 | 0.193 | 0.433 | Antiinflammatory | 0.433 0.12 DBMET02749 | DBMET02749 | |
| 0.183 | 0.051 | 0.183 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.124 0.102 DBMET02746 0.147 0.076 DBMET02748 | ||
| 0.163 | 0.032 | 0.23 | Granulocyte macrophage colony stimulating factor antagonist | 0.23 0.015 DBMET02746 | DBMET02746 | |
| 0.176 | 0.045 | 0.176 | Cyclin-dependent kinase inhibitor | 0.122 0.072 DBMET02748 | ||
| 0.157 | 0.027 | 0.157 | Protein kinase C gamma inhibitor | 0.094 0.088 DBMET02745 | ||
| 0.15 | 0.027 | 0.15 | CDK3/cyclin E inhibitor | 0.134 0.04 DBMET02746 0.15 0.027 DBMET02748 0.124 0.051 DBMET02745 0.105 0.079 DBMET02747 | ||
| 0.142 | 0.021 | 0.142 | MAP kinase 14 inhibitor | 0.07 0.055 DBMET02746 0.072 0.053 DBMET02748 0.064 0.06 DBMET02747 | ||
| 0.138 | 0.018 | 0.138 | MAP kinase 10 inhibitor | 0.092 0.04 DBMET02746 0.071 0.063 DBMET02748 | ||
| 0.139 | 0.019 | 0.139 | Rho-associated kinase II inhibitor | 0.076 0.049 DBMET02746 0.07 0.056 DBMET02748 | ||
| 0.225 | 0.105 | 0.225 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.125 | 0.006 | 0.125 | Heat shock protein 90 beta antagonist | |||
| 0.145 | 0.026 | 0.145 | Protein kinase A inhibitor | 0.091 0.052 DBMET02746 0.138 0.028 DBMET02748 0.112 0.038 DBMET02745 | ||
| 0.152 | 0.033 | 0.152 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.148 | 0.03 | 0.197 | CDK/cyclin complex inhibitor | 0.081 0.067 DBMET02746 0.09 0.059 DBMET02748 0.197 0.019 DBMET02742 | DBMET02742 | |
| 0.156 | 0.038 | 0.156 | MAP kinase 12 inhibitor | 0.12 0.07 DBMET02746 0.128 0.061 DBMET02748 0.116 0.075 DBMET02745 | ||
| 0.126 | 0.009 | 0.126 | CC chemokine 2 receptor antagonist | 0.074 0.022 DBMET02748 | ||
| 0.199 | 0.083 | 0.199 | MAP kinase kinase 2 inhibitor | |||
| 0.172 | 0.058 | 0.172 | Cyclin-dependent kinase 3 inhibitor | 0.14 0.121 DBMET02746 0.156 0.083 DBMET02748 0.14 0.124 DBMET02745 | ||
| 0.178 | 0.066 | 0.227 | Src kinase inhibitor | 0.192 0.058 DBMET02746 0.227 0.043 DBMET02747 | DBMET02747 | |
| 0.127 | 0.019 | 0.127 | Syk tyrosine kinase inhibitor | |||
| 0.199 | 0.093 | 0.199 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.117 | 0.015 | 0.117 | MAP kinase kinase 8 inhibitor | 0.093 0.026 DBMET02746 0.064 0.055 DBMET02748 0.076 0.038 DBMET02745 | ||
| 0.159 | 0.06 | 0.159 | Activin receptor-like kinase 2 inhibitor | |||
| 0.136 | 0.037 | 0.136 | Check point kinase 2 inhibitor | 0.101 0.064 DBMET02746 0.135 0.038 DBMET02748 0.101 0.064 DBMET02745 | ||
| 0.113 | 0.018 | 0.113 | CDC7 inhibitor | 0.092 0.028 DBMET02748 | ||
| 0.12 | 0.027 | 0.12 | Bcr-Abl kinase inhibitor | |||
| 0.122 | 0.03 | 0.122 | ErbB-4 antagonist | |||
| 0.104 | 0.012 | 0.104 | Protein kinase C beta inhibitor | 0.071 0.046 DBMET02748 | ||
| 0.12 | 0.031 | 0.12 | Pim-3 kinase inhibitor | 0.104 0.041 DBMET02748 | ||
| 0.106 | 0.026 | 0.106 | Focal adhesion kinase 1 inhibitor | 0.073 0.058 DBMET02746 | ||
| 0.098 | 0.019 | 0.098 | MAP kinase kinase 10 inhibitor | 0.075 0.033 DBMET02746 0.061 0.057 DBMET02745 | ||
| 0.147 | 0.069 | 0.147 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.116 | 0.039 | 0.154 | Protein kinase C delta inhibitor | 0.154 0.02 DBMET02746 0.08 0.077 DBMET02745 0.128 0.032 DBMET02747 | DBMET02746 | |
| 0.146 | 0.07 | 0.146 | Vascular endothelial growth factor 3 antagonist | 0.114 0.101 DBMET02748 | ||
| 0.185 | 0.108 | 0.231 | ErbB-1 antagonist | 0.194 0.096 DBMET02742 0.231 0.063 DBMET02745 | DBMET02745 | |
| 0.115 | 0.039 | 0.115 | Hepatocyte growth factor antagonist | |||
| 0.179 | 0.104 | 0.179 | HERG channel blocker | |||
| 0.139 | 0.066 | 0.139 | Aurora-C kinase inhibitor | 0.126 0.091 DBMET02748 | ||
| 0.119 | 0.046 | 0.144 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.144 0.035 DBMET02746 | DBMET02746 | |
| 0.098 | 0.027 | 0.098 | Polo-like kinase-2 inhibitor | |||
| 0.136 | 0.07 | 0.155 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.155 0.058 DBMET02746 | DBMET02746 | |
| 0.132 | 0.067 | 0.132 | c-Src kinase inhibitor | |||
| 0.099 | 0.036 | 0.099 | MAP kinase 11 inhibitor | |||
| 0.145 | 0.083 | 0.145 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.096 | 0.036 | 0.096 | Rho-associated kinase inhibitor | |||
| 0.088 | 0.033 | 0.088 | Tyk2 inhibitor | |||
| 0.226 | 0.171 | 0.246 | Toll-Like receptor 7 agonist | 0.246 0.151 DBMET02746 | DBMET02746 | |
| 0.123 | 0.069 | 0.123 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.153 | 0.099 | 0.153 | Death-associated protein kinase 2 inhibitor | 0.142 0.127 DBMET02746 | ||
| 0.122 | 0.07 | 0.122 | TRKB antagonist | |||
| 0.097 | 0.048 | 0.097 | Stem cell growth factor agonist | |||
| 0.17 | 0.121 | 0.17 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.093 | 0.046 | 0.093 | AXL receptor tyrosine kinase inhibitor | |||
| 0.101 | 0.055 | 0.101 | MAP kinase kinase 1 inhibitor | |||
| 0.089 | 0.043 | 0.089 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.085 0.046 DBMET02748 | ||
| 0.222 | 0.177 | 0.238 | Toll-Like receptor agonist | 0.238 0.159 DBMET02746 | DBMET02746 | |
| 0.081 | 0.038 | 0.081 | Check point kinase 1 inhibitor | 0.075 0.042 DBMET02748 | ||
| 0.134 | 0.092 | 0.134 | Heat shock protein 90 antagonist | |||
| 0.097 | 0.06 | 0.097 | Pim-1 kinase inhibitor | |||
| 0.119 | 0.086 | 0.135 | Lck kinase inhibitor | 0.135 0.075 DBMET02742 | DBMET02742 | |
| 0.106 | 0.074 | 0.106 | Activin receptor-like kinase 4 inhibitor | |||
| 0.038 | 0.008 | 0.038 | 5 Hydroxytryptamine 1F agonist | |||
| 0.096 | 0.069 | 0.096 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.061 | 0.037 | 0.061 | Cyclin A1 inhibitor | |||
| 0.058 | 0.034 | 0.058 | MAP kinase kinase 9 inhibitor | |||
| 0.06 | 0.037 | 0.06 | Fibroblast growth factor 4 antagonist | |||
| 0.151 | 0.134 | 0.151 | Potassium channel blocker | |||
| 0.054 | 0.039 | 0.054 | Pim-2 kinase inhibitor | |||
| 0.063 | 0.048 | 0.063 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.067 | 0.052 | 0.067 | ZAP-70 protein tyrosine kinase inhibitor | |||
| 0.069 | 0.056 | 0.069 | Janus tyrosine kinase 2 inhibitor | |||
| 0.056 | 0.044 | 0.124 | CDK4/cyclin D inhibitor | 0.124 0.009 DBMET02742 | DBMET02742 | |
| 0.062 | 0.052 | 0.062 | Bcl2 antagonist | |||
| 0.055 | 0.045 | 0.059 | Protein kinase C theta inhibitor | 0.059 0.038 DBMET02746 | DBMET02746 | |
| 0.052 | 0.044 | 0.052 | Bruton tyrosine kinase inhibitor | |||
| 0.075 | 0.069 | 0.075 | ErbB-3 antagonist | |||
| 0.052 | 0.046 | 0.15 | CDK4/cyclin D1 inhibitor | 0.15 0.007 DBMET02742 | DBMET02742 | |
| 0.076 | 0.071 | 0.076 | Epidermal growth factor antagonist | |||
| 0.05 | 0.046 | 0.05 | Tyrosine-protein kinase EMT inhibitor | |||
| 0.119 | 0.116 | 0.119 | MAP3K9 inhibitor | |||
| 0.048 | 0.046 | 0.048 | Nicotinic alpha7 receptor agonist | |||
| 0.05 | 0.049 | 0.05 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.057 | 0.071 | 0.09 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.09 0.034 DBMET02746 | DBMET02746 | |
| 0.039 | 0.054 | 0.046 | Parathyroid hormone antagonist | 0.046 0.03 DBMET02748 | DBMET02748 | |
| 0.069 | 0.09 | 0.084 | Platelet activating factor beta antagonist | 0.084 0.075 DBMET02746 | DBMET02746 | |
| 0.035 | 0.056 | 0.051 | Poly(ADP-ribose) polymerase inhibitor | 0.051 0.022 DBMET02746 | DBMET02746 | |
| 0.042 | 0.064 | 0.069 | EphB4 antagonist | 0.069 0.031 DBMET02746 | DBMET02746 | |
| 0.024 | 0.059 | 0.043 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.043 0.021 DBMET02746 | DBMET02746 | |
| 0.142 | 0.19 | 0.176 | MAP kinase kinase 5 inhibitor | 0.176 0.071 DBMET02742 | DBMET02742 | |
| 0.112 | 0.17 | 0.127 | CC chemokine 6 receptor antagonist | 0.127 0.085 DBMET02749 | DBMET02749 | |
| 0.181 | 0.261 | 0.279 | Analgesic | 0.279 0.158 DBMET02746 | DBMET02746 | |
| 0.033 | 0.18 | 0.082 | Protein kinase B beta inhibitor | 0.082 0.04 DBMET02745 | DBMET02745 | |
| 0.029 | 0.189 | 0.424 | Cyclin B3 inhibitor | 0.424 0.003 DBMET02742 | DBMET02742 | |
| 0.022 | 0.185 | 0.182 | Cyclin B1 inhibitor | 0.182 0.005 DBMET02742 | DBMET02742 | |
| 0.034 | 0.207 | 0.067 | HIV-1 integrase inhibitor | 0.067 0.054 DBMET02745 | DBMET02745 | |
| 0.018 | 0.201 | 0.171 | Cyclin B inhibitor | 0.171 0.005 DBMET02742 | DBMET02742 | |
| 0.013 | 0.239 | 0.166 | Cyclin B2 inhibitor | 0.166 0.005 DBMET02742 | DBMET02742 | |
| 0.102 | 0.353 | 0.184 | Immunomodulator | 0.184 0.183 DBMET02749 | DBMET02749 | |
| 0.014 | 0.284 | 0.093 | Phosphodiesterase 4D inhibitor | 0.093 0.04 DBMET02742 | DBMET02742 | |
| 0.06 | 0.367 | 0.156 | Tumour necrosis factor alpha release inhibitor | 0.156 0.151 DBMET02749 | DBMET02749 | |
| 0.008 | 0.376 | 0.108 | Phosphodiesterase 4C inhibitor | 0.108 0.013 DBMET02742 | DBMET02742 | |
| 0.004 | 0.4 | 0.128 | Cholecystokinin A antagonist | 0.128 0.005 DBMET02742 | DBMET02742 | |
| 0.029 | 0.439 | 0.134 | Cholinergic | 0.134 0.091 DBMET02749 | DBMET02749 | |
| 0.004 | 0.447 | 0.139 | Cholecystokinin antagonist | 0.139 0.005 DBMET02742 | DBMET02742 | |
| 0.042 | 0.521 | 0.173 | Hepatoprotectant | 0.173 0.086 DBMET02749 | DBMET02749 | |
| 0.004 | 0.491 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.025 DBMET02745 | DBMET02745 | |
| 0.003 | 0.521 | 0.034 | Cholecystokinin B antagonist | 0.034 0.018 DBMET02742 | DBMET02742 | |
| 0.044 | 0.584 | 0.189 | Hypoglycemic | 0.189 0.123 DBMET02749 | DBMET02749 | |
| 0.038 | 0.578 | 0.269 | Immunosuppressant | 0.269 0.135 DBMET02749 | DBMET02749 | |
| 0.014 | 0.569 | 0.109 | Acetylcholinesterase inhibitor | 0.109 0.09 DBMET02749 | DBMET02749 | |
| 0.011 | 0.591 | 0.045 | Antibiotic Aminoglycoside-like | 0.045 0.017 DBMET02749 | DBMET02749 | |
| 0.009 | 0.607 | 0.048 | Protein 50S ribosomal subunit inhibitor | 0.048 0.043 DBMET02749 | DBMET02749 | |
| 0.066 | 0.746 | 0.261 | Peptidyltransferase inhibitor | 0.261 0.044 DBMET02749 | DBMET02749 | |
| 0.009 | 0.738 | 0.266 | Free radical scavenger | 0.204 0.094 DBMET02742 0.266 0.062 DBMET02749 | DBMET02749 | |
| 0.01 | 0.77 | 0.162 | Vasodilator | 0.162 0.14 DBMET02749 | DBMET02749 | |
| 0.05 | 0.821 | 0.215 | Interleukin 2 agonist | 0.215 0.165 DBMET02749 | DBMET02749 | |
| 0.004 | 0.784 | 0.078 | Selectin antagonist | 0.078 0.038 DBMET02749 | DBMET02749 | |
| 0.005 | 0.898 | 0.099 | Bronchodilator | 0.099 0.065 DBMET02747 | DBMET02747 | |
| 0.005 | 0.911 | 0.469 | Antibacterial | 0.469 0.05 DBMET02749 | DBMET02749 | |
| 0.007 | 0.936 | 0.228 | Angiogenesis stimulant | 0.228 0.08 DBMET02749 | DBMET02749 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |